Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung function impairment at pulmonary TB and HIV/TB diagnosis: a South African cross-sectional cohort analysis.

BMJ open respiratory research·2026
Same author

A spatially coordinated keratinocyte-fibroblast circuit recruits MMP9<sup>+</sup> myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity.

Nature immunology·2026
Same author

Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Complement profiling for treatment outcomes in pulmonary TB.

Frontiers in immunology·2026
Same author

Erratum: Quality and stability studies of red blood cell concentrates from umbilical cord blood compared to their adult counterparts.

Blood transfusion = Trasfusione del sangue·2026
Same author

NR4A1 limits CD8<sup>+</sup> T Cell effector responses and protection in tuberculosis.

Research square·2026

Related Experiment Video

Updated: May 3, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.3K

Diabetes and immunity to tuberculosis.

Nuria Martinez1, Hardy Kornfeld

  • 1Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

European Journal of Immunology
|January 23, 2014
PubMed
Summary

The growing prevalence of diabetes significantly impacts tuberculosis (TB) defense and outcomes. Understanding this dual burden offers insights into human immunity relevant to the general population.

Keywords:
Bacterial infectionsDiabetesHost/pathogen interactionInfectious diseaseTuberculosis

More Related Videos

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

21.3K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Related Experiment Videos

Last Updated: May 3, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.3K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

21.3K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Endocrinology

Background:

  • The co-occurrence of tuberculosis (TB) and diabetes presents a significant global health challenge.
  • Rising diabetes rates in TB-endemic regions exacerbate this dual burden.
  • Existing research on diabetes' effects on immunity relevant to TB is limited and requires human verification.

Purpose of the Study:

  • To review the clinical and epidemiological aspects of TB in diabetic individuals.
  • To connect these features with current understanding of TB susceptibility and diabetes complications.
  • To identify key areas for future research in the diabetes-TB interaction.

Main Methods:

  • Literature review of clinical and epidemiological data.
  • Synthesis of recent advances in immunology and disease mechanisms.
  • Identification of knowledge gaps and future research directions.

Main Results:

  • Diabetes significantly influences the clinical presentation and outcomes of TB.
  • Mechanistic insights into immune dysfunction in diabetes are emerging but require further validation.
  • Geographic, host, pathogen, and epigenetic factors play crucial roles in the diabetes-TB interaction.

Conclusions:

  • The interplay between diabetes and TB necessitates further investigation into immune responses.
  • Understanding hyperglycemia's impact on epigenetic reprogramming and lung injury is critical.
  • Addressing the dual burden requires a multifaceted approach considering host, pathogen, and environmental factors.